Filaci Gilberto, Fravega Marco, Negrini Simone, Procopio Francesco, Fenoglio Daniela, Rizzi Marta, Brenci Sabrina, Contini Paola, Olive Daniel, Ghio Massimo, Setti Maurizio, Accolla Roberto S, Puppo Francesco, Indiveri Francesco
Department of Internal Medicine, and Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
Hum Immunol. 2004 Feb;65(2):142-56. doi: 10.1016/j.humimm.2003.12.001.
Nonantigen specific CD8+ suppressor T lymphocytes (CD8+ Ts) inhibit T-cell proliferation of antigen-specific T lymphocytes. The impossibility to generate in vitro these cells has been correlated with the appearance of relapses in patients affected by autoimmune diseases, suggesting the involvement of these cells in immune regulation. This study was aimed to identify circulating precursors and to characterize the phenotype and mechanism of action of CD8+ Ts. We found that CD8+ Ts can be generated in vitro from CD8+CD28- T lymphocytes, but not from CD8+CD28+ T cells. A key role in their generation is played by monocytes that secrete interleukin-10 (IL-10) after granulocyte macrophage-colony-stimulating factor (GM-CSF) stimulation. Cell-to-cell direct interaction between CD8+CD28- T cells and monocytes does not play a role in the generation of CD8+ Ts. CD8+ Ts have a CD45RA+, CD27-, CCR7-, IL-10Ralpha+ phenotype and a TCR Vbeta chain repertoire overlapping that of autologous circulating CD8+ T cells. This phenotype is typical of T lymphocytes previously expanded due to antigen stimulation. Their suppressive effect on T-cell proliferation targets both antigen presenting cells, such as dendritic cells, and antigen-specific T lymphocytes, and is mediated by IL-10. CD8+ Ts suppress also the antigen-specific cytotoxic activity of CTL decreasing the expression of HLA class I molecules on target cells through IL-10 secretion. These findings can be helpful for the better understanding of immune regulatory circuits and for the definition of new pathogenic aspects in autoimmunity and tumor immunology.
非抗原特异性CD8 +抑制性T淋巴细胞(CD8 + Ts)可抑制抗原特异性T淋巴细胞的T细胞增殖。无法在体外生成这些细胞与自身免疫性疾病患者复发的出现相关,这表明这些细胞参与免疫调节。本研究旨在鉴定循环前体细胞,并表征CD8 + Ts的表型和作用机制。我们发现CD8 + Ts可在体外由CD8 + CD28 - T淋巴细胞生成,但不能由CD8 + CD28 + T细胞生成。单核细胞在其生成中起关键作用,单核细胞在粒细胞巨噬细胞集落刺激因子(GM - CSF)刺激后分泌白细胞介素 - 10(IL - 10)。CD8 + CD28 - T细胞与单核细胞之间的细胞间直接相互作用在CD8 + Ts的生成中不起作用。CD8 + Ts具有CD45RA +、CD27 -、CCR7 -、IL - 10Rα +表型,其TCR Vβ链库与自体循环CD8 + T细胞的TCR Vβ链库重叠。这种表型是先前因抗原刺激而扩增的T淋巴细胞的典型特征。它们对T细胞增殖的抑制作用靶向抗原呈递细胞,如树突状细胞,以及抗原特异性T淋巴细胞,并由IL - 10介导。CD8 + Ts还通过分泌IL - 10抑制CTL的抗原特异性细胞毒性活性,降低靶细胞上HLA I类分子的表达。这些发现有助于更好地理解免疫调节回路,并有助于定义自身免疫和肿瘤免疫学中的新致病方面。